- Secretaries: Lisa Shephard / Dawn Stevens (0114) 2712132
Dr David Kiely BSc (Hons), MD, FRCP
I graduated from the University of Edinburgh in 1991 and undertook a period of postgraduate research in Dundee examining the effects of hypoxia, hypercapnia and vasoactive peptides on the pulmonary circulation in man. I completing my clinical training in Cambridge and Papworth and was appointed as the Director of the Sheffield Pulmonary Vascular Disease Unit, in 2001. Our pulmonary hypertension unit is one of the largest in Europe and assesses and manages all forms of adult pulmonary hypertension. With colleagues I am also involved in delivering integrated services for patients with pulmonary embolism and the respiratory complications of connective disease and the provision of acute respiratory services.
I am involved in undergraduate and post-graduate teaching of students. I organise the BTS Short Course on Pulmonary Hypertension and participate in the BTS short course in Pulmonary Embolism. I contribute to an e-learning programme developed by the PHA-UK with Edge Hill University providing credits for degree level for Healthcare professionals.
I am the Pulmonary Hypertension Research Theme lead on the Sheffield Teaching Hospitals Respiratory Medicine Research Executive and lead the Pulmonary Hypertension Clinical Phenotype and Bioresource stream of the Sheffield Pulmonary Hypertension Research Network, where I collaborate closely with Jim Wild and Andrew Swift (Imaging), Allan Lawrie (Pre-clinical models and drug discovery) and my clinical colleagues in pulmonary hypertension Charlie Elliot, Robin Condliffe and Ian Sabore. My research is primarily focused on the assessment and classification of pulmonary hypertension and the use of multimodality imaging. I am particularly interested in the use of imaging modalities to understand more about pulmonary vascular disease and I embrace the concept of an in silico approach. I have participated in multiple randomized controlled trials in pulmonary hypertension leading to the licensing of new treatments and have helped translate new imaging techniques into routine clinical practice. I currently participate in a number of research studies funded by the NIHR, MRC and BHF and am part of a UK collaboration characterizing genes and biomarkers in patients with idiopathic pulmonary arterial hypertension.
- Director of NCG (National Commissioning Group) designated Sheffield pulmonary hypertension centre (2001 onwards)
- Chair of the Pulmonary Vascular Specialist Advisory Group to the British Thoracic Society (2009 until Dec 2012)
- Chair of the UK Pulmonary Hypertension Physicians Committee (April 2013-April 2016)
- Board Member of the International Workshop on Pulmonary Functional Imaging (2009 onwards)
- Board member of Clinical Reference Group (CRG) for Pulmonary Hypertension (2012 onwards)
- Board member of the National Pulmonary Hypertension Audit Reference Group (2013 onwards)
- Member of the Insigneo Institute for in silico medicine insigneo.org
- Fellow American College of Chest Physicians (2000), Fellow Royal College of Physicians (2009), Fellow European Society of Cardiology (2010), Fellow of Pulmonary Vascular Research Institute (2011)